CERE
Cerevel Therapeutics Holdings, Inc.
CHRO Kenneth Dipietro sold $332K of Cerevel Therapeutics Holdings, Inc.
Sold$331,608
$41.45Price
8,000Shares
−24%Stake
What CERE did after the filing
- The stock from Wed, Dec 27 close, $42.30
- +1.4%
- S&P 500, same days
- +5.2%
Measured over 30 trading days, to the Feb 9 close.
Traded Fri, Dec 22. Filed Wed, Dec 27, 11:15 AM ET, during the session. Returns use the Dec 27 close and the Feb 9 close. Not investment advice.